Raj. CHO -2020: Which vaccine can be used for the prevention of Cervical Cancer?

Raj. CHO -2020

Obstetrics & Gynaecology

Easy

Appeared in: Raj. CHO -2020

Explanation

Cervical cancer is primarily caused by persistent infection with high-risk types of Human Papillomavirus (HPV).
The HPV vaccine is specifically designed to protect against these high-risk HPV types, thereby preventing the development of cervical cancer.
High-risk HPV types 16 and 18 are responsible for approximately 70-85% of all cervical cancers.
Vaccination before exposure to the virus is a highly effective primary prevention strategy against cervical cancer and other HPV-related malignancies.

Option A: The IPV (Inactivated Poliovirus Vaccine) provides protection against poliomyelitis, a viral disease that affects the nervous system. It has no role in preventing cervical cancer.
Option B: The Hepatitis B vaccine prevents infection with the Hepatitis B virus. Chronic Hepatitis B infection is a major cause of liver cancer, not cervical cancer.
Option C: The DPT vaccine is a combination vaccine that protects against three distinct bacterial diseases: Diphtheria, Pertussis (whooping cough), and Tetanus. It is unrelated to viral infections or cancer prevention.

Visual 1: Infographic: A flowchart illustrating the progression from HPV infection to the development of cervical cancer, highlighting the point where vaccination intervenes.
Visual 2: Chart: A comparison table of the different HPV vaccines (Bivalent, Quadrivalent, Nonavalent), showing the specific HPV types each vaccine targets and the diseases they prevent.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Vaccination for cancer prevention as background academic context rather than a clinical decision trigger.
Nurses play a crucial role in educating patients and parents about the safety and efficacy of the HPV vaccine to increase uptake rates and prevent future cancer cases.
It is important for nurses to administer the vaccine according to the recommended schedule (2 or 3 doses depending on age) to ensure maximum protection.
What if a patient is older than the recommended age for routine vaccination? Shared clinical decision-making is recommended for individuals aged 27-45, as some may still benefit from vaccination if they are at risk for new HPV infections.

How to Approach the Question

First, read the question carefully to identify the core concept: a vaccine to prevent a specific type of cancer (cervical cancer).
Next, recall or determine the primary cause of cervical cancer. You should identify Human Papillomavirus (HPV) as the main causative agent.
Review the options provided. Evaluate each vaccine based on the disease it is known to prevent.
Option A (IPV) is for Polio. Option B (Hepatitis) is for Hepatitis B, which can cause liver cancer. Option C (DPT) is for Diphtheria, Pertussis, and Tetanus. These are incorrect for cervical cancer.
Option D (HPV) directly corresponds to the causative agent of cervical cancer. This makes it the logical choice for prevention.
Confirm your choice by recognizing that the HPV vaccine is specifically recommended for the prevention of HPV-related diseases, including cervical cancer.

Concept Tested & Keywords

QqKANOoSVrkkbPDpfzT40

E6 OBGY Williams Gynecology 4e p. 456-635